JPWO2021066931A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021066931A5
JPWO2021066931A5 JP2022520680A JP2022520680A JPWO2021066931A5 JP WO2021066931 A5 JPWO2021066931 A5 JP WO2021066931A5 JP 2022520680 A JP2022520680 A JP 2022520680A JP 2022520680 A JP2022520680 A JP 2022520680A JP WO2021066931 A5 JPWO2021066931 A5 JP WO2021066931A5
Authority
JP
Japan
Prior art keywords
composition
seq
gene
nucleic acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022520680A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023503797A5 (https=
JP2023503797A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/044510 external-priority patent/WO2021066931A1/en
Publication of JP2023503797A publication Critical patent/JP2023503797A/ja
Publication of JP2023503797A5 publication Critical patent/JP2023503797A5/ja
Publication of JPWO2021066931A5 publication Critical patent/JPWO2021066931A5/ja
Priority to JP2025132078A priority Critical patent/JP2025166082A/ja
Pending legal-status Critical Current

Links

JP2022520680A 2019-10-01 2020-07-31 分子ガイドシステムペプチド及びその使用 Pending JP2023503797A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025132078A JP2025166082A (ja) 2019-10-01 2025-08-07 分子ガイドシステムペプチド及びその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962908687P 2019-10-01 2019-10-01
US62/908,687 2019-10-01
PCT/US2020/044510 WO2021066931A1 (en) 2019-10-01 2020-07-31 Molecular guide system peptides and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025132078A Division JP2025166082A (ja) 2019-10-01 2025-08-07 分子ガイドシステムペプチド及びその使用

Publications (3)

Publication Number Publication Date
JP2023503797A JP2023503797A (ja) 2023-02-01
JP2023503797A5 JP2023503797A5 (https=) 2023-08-07
JPWO2021066931A5 true JPWO2021066931A5 (https=) 2023-08-07

Family

ID=75337452

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022520680A Pending JP2023503797A (ja) 2019-10-01 2020-07-31 分子ガイドシステムペプチド及びその使用
JP2025132078A Pending JP2025166082A (ja) 2019-10-01 2025-08-07 分子ガイドシステムペプチド及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025132078A Pending JP2025166082A (ja) 2019-10-01 2025-08-07 分子ガイドシステムペプチド及びその使用

Country Status (6)

Country Link
US (1) US20220380764A1 (https=)
EP (2) EP4360655A3 (https=)
JP (2) JP2023503797A (https=)
CN (1) CN115243699A (https=)
AU (1) AU2020357455B2 (https=)
WO (1) WO2021066931A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240287148A1 (en) * 2021-07-15 2024-08-29 Cornell University Engineered biomolecules for nutrient reprogramming
US12516086B2 (en) 2021-12-21 2026-01-06 Sri International Dual targeting for cell-specific delivery to the central nervous system
WO2025006452A2 (en) * 2023-06-26 2025-01-02 Sri International NEU5GC-LEWISa-TARGETING MOLECULES AND USES THEREOF IN CANCER
WO2025240414A1 (en) * 2024-05-14 2025-11-20 Sri International Cardiomyocyte-specific molecular guidance system peptides and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090110662A1 (en) * 2007-04-30 2009-04-30 Intezyne Technologies, Inc. Modification of biological targeting groups for the treatment of cancer
WO2009089186A2 (en) * 2008-01-05 2009-07-16 Sloan-Kettering Institute For Cancer Research Peptide-conjugated oligonucleotide therapeutic and method of making and using same
PT3137605T (pt) * 2014-05-01 2020-12-18 Ionis Pharmaceuticals Inc Composições e métodos para modulação da expressão de angiopoietina de tipo 3
US11965004B2 (en) * 2017-07-10 2024-04-23 Sri International Molecular guide system peptides and uses thereof
CN118240025A (zh) * 2017-07-10 2024-06-25 斯坦福国际研究院 用于治疗癌症的肽皂草素缀合物
WO2019017199A1 (ja) * 2017-07-21 2019-01-24 株式会社豊田自動織機 正極活物質

Similar Documents

Publication Publication Date Title
Kundu et al. Synthesis of phosphorodiamidate morpholino oligonucleotides using trityl and fmoc chemistry in an automated oligo synthesizer
CN111989113B (zh) 用于治疗癌症的包含向导rna和核酸内切酶作活性成分的药物组合物
CA3035910A1 (en) Methods and compositions for modulating gene expression
JP2007135605A (ja) 核酸構築物
CN107709555A (zh) 用于Cas9介导的基因编辑的合成的单向导RNA
IL296426A (en) Maran"im that underwent a change for the development of a component
JP2022023144A5 (https=)
Ling et al. Genome editing mRNA nanotherapies inhibit cervical cancer progression and regulate the immunosuppressive microenvironment for adoptive T-cell therapy
JP2025081638A5 (https=)
JP2005529959A (ja) 細胞へのポリヌクレオチドの伝達をするための新規な方法
US20240327847A1 (en) Compositions and methods for rna affinity
NZ521564A (en) Compositions for drug delivery
CN112673106A (zh) 点击修饰的mRNA
JP2021523733A (ja) 動物病原体由来ポリペプチドおよびその遺伝子工学的利用
Staroseletz et al. ‘Dual’peptidyl-oligonucleotide conjugates: Role of conformational flexibility in catalytic cleavage of RNA
JPWO2021187392A5 (https=)
JPWO2021066931A5 (https=)
Maina et al. Solid-phase synthesis, characterization and RNAi activity of branch and hyperbranch siRNAs
US20210332094A1 (en) Novel transcription activator
KR20240040112A (ko) 방법
US11845934B2 (en) Specific synthetic chimeric xenonucleic acid guide RNA; s(XNA-gRNA) for enhancing CRISPR mediated genome editing efficiency
CN115244176A (zh) 向导rna-cas蛋白复合物的缀合物
RU2800921C2 (ru) Новый активатор транскрипции
JPWO2021178432A5 (https=)
JP6840914B2 (ja) 細胞膜透過性を有するペプチド、構築物、及び、カーゴ分子を細胞内に輸送する方法